The focus of Core 2 is on biodegradable and biocompatible matrices to be used as custom-designed scaffolds in tissue engineering. Scaffolds will be optimized via chemistry and processing to interact with mesenchymal progenitor cells (MPCs) and human embryonic stem cells (hESCs) (Core 1) within environments of bioreactors (Core 3).
Our aim i s to gain fundamental insight into the communication between matrices and stem cells as a route to improve scaffold design and function. Our hypothesis is that an improved match between scaffold design (chemistry, morphology and structure from the molecular to macro-scale perspective) and stem cells will lead to improved structure and function of engineered tissues. The extent to which this improved 'communication' controls cell responses and tissue outcomes is virtually an untapped area of scientific inquiry. Thus there is a great deal of insight to be gained and applied to critical questions in biology related to surface interactions with cells. The available evidence in the literature, and from our own preliminary studies, suggests that this is an important topic that requires detailed inquiry in order to improve specific tissue engineering strategies. Matrix-cell relationships can be in the form of the chemical and/or physical interactions with the adherent cells. A key aspect of this core is the design and characterization of tissue engineering scaffolds with desired ranges of surface chemistries, degradation rates, mechanical properties and morphologies. Generating suitable polymer scaffolds is a critical step in functional tissue engineering and the team at Tufts has extensive experience in this area. We plan to build on our strong base of biopolymer synthesis and processing and associated inquiry into cell responses as a basis for this core activity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Biotechnology Resource Grants (P41)
Project #
1P41EB002520-01A1
Application #
6956303
Study Section
Special Emphasis Panel (ZRG1-BST-D (40))
Project Start
2004-08-15
Project End
2009-07-31
Budget Start
2004-08-15
Budget End
2005-07-31
Support Year
1
Fiscal Year
2004
Total Cost
$20,001
Indirect Cost
Name
Tufts University
Department
Type
DUNS #
073134835
City
Medford
State
MA
Country
United States
Zip Code
02155
Huang, Wenwen; Ling, Shengjie; Li, Chunmei et al. (2018) Silkworm silk-based materials and devices generated using bio-nanotechnology. Chem Soc Rev 47:6486-6504
Ronaldson-Bouchard, Kacey; Ma, Stephen P; Yeager, Keith et al. (2018) Advanced maturation of human cardiac tissue grown from pluripotent stem cells. Nature 556:239-243
Marturano-Kruik, Alessandro; Nava, Michele Maria; Yeager, Keith et al. (2018) Human bone perivascular niche-on-a-chip for studying metastatic colonization. Proc Natl Acad Sci U S A 115:1256-1261
Algarrahi, Khalid; Affas, Saif; Sack, Bryan S et al. (2018) Repair of injured urethras with silk fibroin scaffolds in a rabbit model of onlay urethroplasty. J Surg Res 229:192-199
Algarrahi, Khalid; Franck, Debra; Savarino, Alyssa et al. (2018) Bilayer silk fibroin grafts support functional oesophageal repair in a rodent model of caustic injury. J Tissue Eng Regen Med 12:e1068-e1075
Chen, Timothy; Vunjak-Novakovic, Gordana (2018) In vitro Models of Ischemia-Reperfusion Injury. Regen Eng Transl Med 4:142-153
Wobma, Holly M; Tamargo, Manuel A; Goeta, Shahar et al. (2018) The influence of hypoxia and IFN-? on the proteome and metabolome of therapeutic mesenchymal stem cells. Biomaterials 167:226-234
Ling, Shengjie; Wang, Qi; Zhang, Dong et al. (2018) Integration of stiff graphene and tough silk for the design and fabrication of versatile electronic materials. Adv Funct Mater 28:
Dinjaski, Nina; Huang, Wenwen; Kaplan, David L (2018) Recursive Directional Ligation Approach for Cloning Recombinant Spider Silks. Methods Mol Biol 1777:181-192
Liu, Bohao; Lee, Benjamin W; Nakanishi, Koki et al. (2018) Cardiac recovery via extended cell-free delivery of extracellular vesicles secreted by cardiomyocytes derived from induced pluripotent stem cells. Nat Biomed Eng 2:293-303

Showing the most recent 10 out of 610 publications